APA (7th ed.) Citation

Yarnoff, B., Neary, M. P., Gabriel, V., Ghemmouri, M., Hodges, E. N., Tribaldos, M., . . . Krilov, L. R. (2026). Estimation of Public Health Impact with Use of Nirsevimab During the 2024–2025 RSV Season in the USA: A Modeling Study. Pulmonary Therapy, 12(2), 707. https://doi.org/10.1007/s41030-026-00348-z

Chicago Style (17th ed.) Citation

Yarnoff, Benjamin, et al. "Estimation of Public Health Impact with Use of Nirsevimab During the 2024–2025 RSV Season in the USA: A Modeling Study." Pulmonary Therapy 12, no. 2 (2026): 707. https://doi.org/10.1007/s41030-026-00348-z.

MLA (9th ed.) Citation

Yarnoff, Benjamin, et al. "Estimation of Public Health Impact with Use of Nirsevimab During the 2024–2025 RSV Season in the USA: A Modeling Study." Pulmonary Therapy, vol. 12, no. 2, 2026, p. 707, https://doi.org/10.1007/s41030-026-00348-z.